AIM: To study the SSTR1, 2, 3, 4, 5 expression and their relationships with clinico-
pathological factors, cell proliferation, Bcl-2 and p53 expression in colorectal cancer cells …

Eur J Clin Invest 2012; 42 (7): 777–783 Abstract Background To determine the
immunohistochemical expression levels of the somatostatin receptor subtypes 2 and 5 (Sst2 …

Purpose: The somatostatin (SS) receptor subtype 2 (sst2) is the principal mediator of the
antiproliferative effects of SS and has the highest affinity for the commercially available SS …

The clinical relevance of the somatostatin receptor subtype 2 (sst2) is well defined in
neuroendocrine tumors but it is still a matter of debate whether its expression may have a …

Results SSTR1 expression was found in 31 (75.6%) and SSTR5 expression in 21 of (51.2%)
41 biopsies. SSTR1 and SSTR5 expressions were not determined in 10 (24.4%) and 20 …

Somatostatin analogues may be useful novel agents in the systemic treatment of advanced
colorectal cancer, as somatostatin inhibits proliferation in a wide variety of cell types. Here …

Background The aim of this study is to investigate the expressions of somatostatin receptor
(SSTR), SSTR-2, SSTR-3, and SSTR-5, in pancreatic tissue and non-cancerous tissue and …

Results Compared to surrounding cirrhotic tissues, mRNA levels of SSTR-2 and-5 in HCCs
were significantly reduced. Seventy six HCC patients were divided into two groups …

Colon adenocarcinoma (COAD) is among the most prevalent cancers worldwide, ranking as
the third most prevalent malignancy in incidence and mortality. The somatostatin receptor …

In the present study, we detected the expression of SSTR3 protein in 40 patients with gastric
adenocarcinoma and 40 cases of normal gastric mucosa by immunoperoxidased staining …